|Announcement Title||General Announcement|
|Date & Time of Broadcast||Oct 26, 2023 20:59|
|Announcement Sub Title||Proposed Voluntary Delisting and Exit Offer for Healthway Medical Corporation Limited|
|Submitted By (Co./ Ind. Name)||Mr. Yet Kum Meng|
|Designation||Chief Executive Officer and Executive Director|
|Description (Please provide a detailed description of the event in the box below)||Reference is made to:
(a) the Company's announcements dated 3 July 2023, 5 September 2023, 27 September 2023, 28 September 2023 and 10 October 2023 in relation to the exit offer by OUEH Investments Pte. Ltd. (the "Offeror"), a wholly-owned subsidiary of the Company, for the proposed voluntary delisting (the "Delisting") of Healthway Medical Corporation Limited ("HMC") (the "Exit Offer"); and
(b) the Company's announcement dated 3 July 2023 in relation to, inter alia, the Exit Offer being a discloseable transaction under Rule 1010 of the SGX-ST Listing Manual Section B: Rules of Catalist.
In connection with the Exit Offer, an announcement has been issued today by Oversea-Chinese Banking Corporation Limited for and on behalf of the Offeror on, amongst others:
(a) close of the Exit Offer; and
(b) the final level of valid acceptances received in respect of the Exit Offer.
As announced for and on behalf of the Offeror, the Offeror has received valid acceptances in respect of 1,189,993,563 shares in the capital of HMC ("HMC Shares"), representing approximately 26.24% of the total number of issued HMC Shares. Following the close of the Exit Offer, the acquisition of the HMC Shares by the Offeror has been completed. The Company is accordingly deemed interested in 1,189,993,563 HMC Shares, representing approximately 26.24% of the total number of issued HMC Shares. The Offeror and its concert parties own, control or have agreed to acquire (including by way of valid acceptances of the Exit Offer) an aggregate of 3,108,353,728 HMC Shares, representing approximately 68.53% of the total number of issued HMC Shares.
Settlement of acceptances of the Exit Offer will be made by the Offeror in accordance with Rule 30 of the Singapore Code on Take-overs and Mergers.
Please refer to the attached file for further details.
This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, email@example.com.